A Study of Cerebral-circulatory Response to Intravenous Antihypertensive Treatment in Women With Serious Preeclampsia

The recruitment status of this study is unknown because the information has not been verified recently.
Verified September 2009 by Oslo University Hospital.
Recruitment status was  Recruiting
Sponsor:
Information provided by:
Oslo University Hospital
ClinicalTrials.gov Identifier:
NCT00403572
First received: November 22, 2006
Last updated: September 15, 2009
Last verified: September 2009
  Purpose

The purpose of this study is a systematical registration of hemodynamic measurements (cardiac output, blood pressure and systemic vascular resistance) in women with serious preeclampsia.


Condition Phase
Preeclampsia
Phase 4

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: A Study of Cerebral-circulatory Response to Intravenous Antihypertensive Treatment in Women With Serious Preeclampsia

Resource links provided by NLM:


Further study details as provided by Oslo University Hospital:

Primary Outcome Measures:
  • Hemodynamic and cerebral-circulatory variations in preeclamptic women [ Time Frame: days ] [ Designated as safety issue: No ]

Estimated Enrollment: 50
Study Start Date: November 2006
Estimated Study Completion Date: May 2009
Estimated Primary Completion Date: January 2009 (Final data collection date for primary outcome measure)
  Eligibility

Ages Eligible for Study:   18 Years to 50 Years
Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Pregnant women with moderate-to-severe pre-eclapmsia

Criteria

Inclusion Criteria:

  • Women with serious preeclampsia
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00403572

Contacts
Contact: Eldrid Langesæter, MD + 47 23073000 eldrid.langesaeter@rikshospitalet.no

Locations
Norway
Rikshospitalet-Radiumhospitalet HF Recruiting
Oslo, Norway, 0027
Sponsors and Collaborators
Oslo University Hospital
Investigators
Principal Investigator: Eldrid Langesæter, MD Oslo University Hospital
  More Information

No publications provided

Responsible Party: Rikshospitalet-Radiumhospitalet HF
ClinicalTrials.gov Identifier: NCT00403572     History of Changes
Other Study ID Numbers: ElangeTCD-2006, S-06348b
Study First Received: November 22, 2006
Last Updated: September 15, 2009
Health Authority: Norway: The Data Inspectorate
Norway: Directorate of Health

Keywords provided by Oslo University Hospital:
Preeclampsia
Trans cranial Doppler
Cardiac output
systemic vascular resistance
blood pressure

Additional relevant MeSH terms:
Pre-Eclampsia
Hypertension, Pregnancy-Induced
Pregnancy Complications
Antihypertensive Agents
Cardiovascular Agents
Therapeutic Uses
Pharmacologic Actions

ClinicalTrials.gov processed this record on October 01, 2014